FHA
SGMO

First Horizon Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

First Horizon Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-41
Closed – – 2418
2021
Q3 		$0 Buy
+41
New +$405 ﹤0.01% 2407

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

First Horizon Advisors's SGMO Position: Q4 2021 in Review

First Horizon Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2021, closing a stake of 41 shares.

First Horizon Advisors first reported a position in SGMO in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 193 funds tracked by Wall St. Rank hold SGMO as of Q4 2021.

  • First Horizon Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2021 after selling out during the quarter.
  • First Horizon Advisors sold 41 SANGAMO THERAPEUTICS INC shares in Q4 2021.
  • First Horizon Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q3 2021 and held it in 1 quarter.
  • First Horizon Advisors's SANGAMO THERAPEUTICS INC position peaked at $0 in Q3 2021.
  • 193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2021.

Based on First Horizon Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.